SOUTHEASTERN ASSET MANAGEMENT INC/TN/
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 27 quarters, returned +2.8% per quarter — versus +3.5% per quarter from simply owning every 13F stock. It beat that baseline in only 44.4% of quarters (excess t = -1.20, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 49 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| RYN | $222M | | ADD |
| MAT | $186M | | ADD |
| PPLI | $161M | | HOLD |
| CNX | $155M | | TRIM |
| ACI | $126M | | ADD |
| REGN | $101M | | TRIM |
| KHC | $89M | | TRIM |
| FDX | $88M | | TRIM |
| FBIN | $84M | | ADD |
| MGM | $62M | | TRIM |
| PVH | $51M | | HOLD |
| GLIBK | $49M | | HOLD |
| TRIP | $49M | | ADD |
| BIO | $45M | | TRIM |
| SHEN | $45M | | HOLD |
| WTM | $41M | | TRIM |
| CNH | $41M | | HOLD |
| GHC | $40M | | ADD |
| FIS | $39M | | ADD |
| ESRT | $34M | | ADD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
None.
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.